Fluorouracil

interferon alpha 1 ; Homo sapiens







125 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
101 8339255 Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer. 1993 Aug 1 1
102 8418225 Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial. 1993 Jan 2
103 8426214 Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. 1993 Feb 3
104 8435370 5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: a pilot study. 1993 Jan 1
105 8509231 Clinical and pharmacological studies of interferon and chemotherapy in gastrointestinal and breast cancer. 1993 2
106 1370257 A dual anti-tumor effect of a combination of interferon-alpha or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity. 1992 Jan 1
107 1372764 Antineoplastic activity of the combination of 5-fluorouracil and interferon: preclinical and clinical results. 1992 Apr 5
108 1421872 Interferon alpha-2a shows antitumor activity in combination with 5-fluorouracil against human colon carcinoma xenografts: a study in reference to thymidylate synthetase activity inhibition. 1992 3
109 1498068 Double biochemical modulation of 5-fluorouracil by leucovorin and cyclic low dose interferon alpha 2b in advanced colorectal cancer patients. 1992 Jun 2
110 1525760 A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. 1992 Oct 1 2
111 1537082 Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study. 1992 1
112 1540167 Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells. 1992 Feb 14 7
113 1553576 A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. 1992 Apr 2
114 1557647 A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. 1992 Apr 2
115 1557648 Treatment of refractory colorectal carcinomas with fluorouracil, folinic acid, and interferon alfa-2a. 1992 Apr 2
116 1557649 Fluorouracil continuous infusion plus alfa interferon plus oral folinic acid in advanced colorectal cancer. 1992 Apr 1
117 1557650 Combination fluorouracil, folinic acid, and interferon alfa-2a: an active regimen in advanced pancreatic carcinoma. 1992 Apr 1
118 1557651 Biochemical modulation of 5-fluorouracil by folinic acid or alpha-interferon with and without other cytostatic drugs in gastric, esophageal, and pancreatic cancer. 1992 Apr 6
119 1626952 [Biochemical modulation of 5-FU with interferon]. 1992 Jul 1
120 1719644 Mechanisms of interaction of interferon and 5-fluorouracil in solid tumors. 1991 Oct 2
121 1781811 [Pharmacokinetic aspects of the combination of interferon-alpha-2b and folic acid with fluorouracil]. 1991 Aug 1
122 1931710 Rational basis for the metabolic modulation of 5-fluorouracil by leucovorin and interferon alpha. 1991 Oct 2
123 1697499 Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. 1990 Sep 15 3
124 2249187 Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity. 1990 Dec 15 3
125 3416325 Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy. 1988 1